Cargando…

Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal

Detalles Bibliográficos
Autores principales:	Shrestha, Bhola R, Pandey, Deb P, Acharya, Krishna P, Thapa-Magar, Chhabilal, Mohamed, Fahim, Isbister, Geoffrey K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2017
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689198/ https://www.ncbi.nlm.nih.gov/pubmed/29147044 http://dx.doi.org/10.2471/BLT.17.195453

Ejemplares similares

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

In-Vitro Neutralization of the Neurotoxicity of Coastal Taipan Venom by Australian Polyvalent Antivenom: The Window of Opportunity
por: Madhushani, Umesha, et al.
Publicado: (2020)

Analysis of News Media-Reported Snakebite Envenoming in Nepal during 2010–2022
por: Pandey, Deb P., et al.
Publicado: (2023)

A season of snakebite envenomation: presentation patterns, timing of care, anti-venom use, and case fatality rates from a hospital of southcentral Nepal
por: Pandey, Deb P, et al.
Publicado: (2016)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies
por: Maduwage, Kalana, et al.
Publicado: (2016)

Cross Neutralization of Afro-Asian Cobra and Asian Krait Venoms by a Thai Polyvalent Snake Antivenom (Neuro Polyvalent Snake Antivenom)
por: Leong, Poh Kuan, et al.
Publicado: (2012)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

Polyvalent Snake Antivenoms: Production Strategy and Their Therapeutic Benefits
por: Ratanabanangkoon, Kavi
Publicado: (2023)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Effect of Indian Polyvalent Antivenom in the Prevention and Reversal of Local Myotoxicity Induced by Common Cobra (Naja naja) Venom from Sri Lanka In Vitro
por: Madhushani, Umesha, et al.
Publicado: (2021)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

In Vitro Neutralization of the Myotoxicity of Australian Mulga Snake (Pseudechis australis) and Sri Lankan Russell’s Viper (Daboia russelii) Venoms by Australian and Indian Polyvalent Antivenoms
por: Thakshila, Prabhani, et al.
Publicado: (2022)

Indian Polyvalent Antivenom Accelerates Recovery From Venom-Induced Consumption Coagulopathy (VICC) in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
por: Silva, Anjana, et al.
Publicado: (2022)

A polyvalent coral snake antivenom with broad neutralization capacity
por: Castillo-Beltrán, María Carlina, et al.
Publicado: (2019)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)

Antivenom availability, delays and use in Australia
por: Isbister, Geoffrey K.
Publicado: (2022)

Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)
por: Allen, George E., et al.
Publicado: (2012)

Multilevel Comparison of Indian Naja Venoms and Their Cross-Reactivity with Indian Polyvalent Antivenoms
por: Deka, Archana, et al.
Publicado: (2023)

Viper and Cobra Venom Neutralization by Alginate Coated Multicomponent Polyvalent Antivenom Administered by the Oral Route
por: Bhattacharya, Sourav, et al.
Publicado: (2014)

Effectiveness of repeated antivenom therapy for snakebite-related systemic complications
por: Park, Kyung Hoon, et al.
Publicado: (2019)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

A Randomised Controlled Trial of Two Infusion Rates to Decrease Reactions to Antivenom
por: Isbister, Geoffrey K., et al.
Publicado: (2012)

Public perceptions of snakes and snakebite management: implications for conservation and human health in southern Nepal
por: Pandey, Deb Prasad, et al.
Publicado: (2016)

In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms
por: Chaisakul, Janeyuth, et al.
Publicado: (2020)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming
por: Silva, Anjana, et al.
Publicado: (2017)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Snakebite in the Hills and Mountains of Nepal
por: Bogati, Sunil, et al.
Publicado: (2022)

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Use of Molecular Diagnostic Tools for the Identification of Species Responsible for Snakebite in Nepal: A Pilot Study
por: Sharma, Sanjib Kumar, et al.
Publicado: (2016)

Circulating microvesicles in snakebite patients with microangiopathy
por: Enjeti, Anoop K., et al.
Publicado: (2018)

Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae
por: García-Arredondo, Alejandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o8507hej3jd8levah82aftrt15